Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AMN1 antisense RNA 1 (AMN1-AS1; AC023157.3) is a long non-coding antisense RNA transcribed from the opposite DNA strand at the AMN1 gene locus. Like other natural antisense transcripts (NATs), AMN1-AS1 is assumed to play a role in the regulation of gene expression at the AMN1 sense gene, likely through cis-acting mechanisms including transcriptional interference and/or modulation of RNA stability or chromatin structure. There is no evidence that AMN1-AS1 encodes a protein, acts as a receptor, enzyme, or typical therapeutic target class. There are currently no known drugs, clinical biomarkers, or established disease associations tied specifically to AMN1-AS1[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMN1 antisense RNA 1 (AMN1-AS1).